Location: Home
  • search
  • go
  • Relate News
  • 3/17/2025BeiGene and Amgen Launch Phase 1 Trial of Tarlatamab + YL201 in China
  • 3/17/2025SinoCellTech Advances PD-1/VEGF Bispecific SCTB14 into Phase 2/3 for E...
  • 3/17/2025China Suspends Imports of Five APIs from Kyowa Hakko Bio's Hofu Plant
  • 3/17/2025NMPA Solicits Comments on Draft Revision of GMP Annex for Sterile Drug...
  • 3/17/2025Visirna Announce Positive Topline Results from Phase 3 Trial of Ploza...
  • 3/17/2025Innovent Launches GLORY-3: A Phase 3 Head-to-Head Study of Mazdutide v...
  • 3/14/2025Roche's Itovebi (Inavolisib) Wins Approval in China for Advanced Breas...
  • 3/14/2025BioCity Announces Clinical Collaboration to Evaluate BC3195 in Combo w...
  • 3/14/2025Pyrotech's PTT-936 Gains Approval for Clinical Trials in China for Adv...
  • 3/14/2025Fosun Pharma to Divest United Family Healthcare for $124.1M
  • 3/14/2025Zai Lab/Pfizer's BLA for Tivdak Accepted in China
  • 3/14/2025Innovent's IBI311 Becomes First Chinese-Made IGF-1R Antibody Approved ...
  • 3/14/2025Recent Executive Moves
  • 3/14/2025PharmCube's Overview and Insights into China's Pharmaceutical Market 2...
  • 3/13/2025AskBio Receives FDA Regenerative Medicine Advanced Therapy designation...
  • 3/13/2025China Issues Guidelines for Informatization of County-Level Healthcare...
  • 3/13/2025Insilico Medicine Secures $110M, Explores IPO Amid AI Drug Discovery B...
  • 3/12/2025Akeso Initiates Phase III Trial of Ivonescimab Plus Chemotherapy for m...
  • 3/12/2025CSPC Advances Phase II Trial of Nectin-4 ADC SYS6002 for Advanced HNSC...
  • 3/12/2025Eli Lilly Plans Late 2025 Launch of Weight Loss Drugs in China and Ind...
  • 3/12/2025Pfizer's PD-L1 Targeting ADC Receives Clinical Trial Approval in China
  • 3/12/2025CDE Publicizes the List of Reference Formulations for GQCE Studies (91...
  • 3/12/2025Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generati...
  • 3/12/2025Novartis' Cosentyx Receives Fifth Indication Approval in China for Hid...
  • 3/12/2025NewDEL Biotech Completes Series A+ Financing Led by XtalPi to Accelera...
  • 3/11/2025TYK Medicines Announces Pivotal Phase II Trial of TY-9591 Vs Osimertin...
  • 3/11/2025InnoCare Presents Promising Phase II Data on ICP-488 for Psoriasis
  • 3/11/2025RockRoc Secures Pre-A+ Financing to Advance Macrophage-Based Cancer Th...
  • 3/11/2025Juvensis Secures Over CNY 100M in Pre-A Financing to Advance Gene The...
  • 3/11/2025Pfizer's Elrexfio Receives Conditional Approval in China for Advanced ...
  • Page:9/764 Total number of articles:22895: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group